Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

Join Innovate Carolina on December 4 for an evening celebrating innovation, invention, and the journey from academic discovery to real-world impact.

Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...

In conjunction with Tract’s move to Connect Labs Charlotte, the company’s scientific co-founders, Frank McKeon, Ph.D., and Wa ...

Global pharmaceutical giant Eli Lilly and Company is investing again in North Carolina, this time announcing a $450 million, 100-plus-worker add-on to its nearly completed $474 million Research ...

Liquidia officials were joined by Pathway Triangle leaders for a groundbreaking ceremony for the company’s new manufacturing ...

A newly established high-powered Research Triangle Park company, APIE Therapeutics, has signed a licensing agreement with RTI International to develop a class of RTI-developed compounds targeting ...

Among the many obstacles between idea and market in life sciences and biotechnology product development, the main challenge is securing capital. NCBiotech offers several business funding programs that ...

With the contract research sector more competitive than ever, and market value forecast to reach almost $150 billion by 2028, operational efficiency and innovation are crucial in delivering clinical ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, said it was recently approved by ...

Are you looking to launch a career in the life sciences? Advance your career? Or inspire the next generation? NCBiotech connects you to resources for training and job opportunities in the life ...

The Translational Research Grant (TRG) program funds research projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions.